Diseases, Conditions, Syndromes

New study may help explain low oxygen levels in COVID-19 patients

A new study published in the journal Stem Cell Reports by University of Alberta researchers is shedding light on why many COVID-19 patients, even those not in hospital, are suffering from hypoxia—a potentially dangerous ...

Medications

Scientists design new drug compound to stop malaria in its tracks

Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop ...

Oncology & Cancer

New patient guidelines on anemia and neutropenia

The National Comprehensive Cancer Network (NCCN) announced today the publication of new NCCN Guidelines for Patients: Anemia and Neutropenia, Low Red and White Blood Cell Counts funded by the NCCN Foundation and endorsed ...

Medical research

Natural immunity to malaria provides clues to potential therapies

WEHI researchers have identified how natural human antibodies can block malaria parasites from entering red blood cells, potentially indicating how new protective therapies could be developed against this globally significant ...

Diseases, Conditions, Syndromes

COVID-19: Who's at higher risk of serious symptoms?

Over a year into the COVID-19 pandemic, it's important to remind people who is more at risk of serious coronavirus disease 2019 (COVID-19) symptoms, which can vary widely. Some people have no symptoms at all, while others ...

Medical research

Anemia discovery points to more effective treatment approaches

A combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation, a new discovery from the University of Virginia School of Medicine suggests.

page 25 from 40